Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Inside PIC/S: The Importance of PIC/S in a Globalized World

October 2, 2011

Pharmaceutical Technology

Expanding the organization's mandate will strengthen inspections.

Pfizer Outlines Its Supply Strategy

October 2, 2011

Pharmaceutical Technology

John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.

Preparing for the Last War

October 2, 2011

Pharmaceutical Technology

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

Report from India

October 2, 2011

Pharmaceutical Technology

In an effort to balance bilateral trade, India is urging China to increase Indian pharmaceutical imports.

Global Health Challenges Spur Vaccine Development

October 2, 2011

Pharmaceutical Technology

Manufacturers fund research and reduce prices to tackle diseases.

Standing Out In The Outsourcing Crowd

October 1, 2011

Pharmaceutical Technology Europe

The contract services industry is a crowded market and it's important for companies to differentiate themselves to stand out.

EU Market Challenges

October 1, 2011

Pharmaceutical Technology Europe

Although the European market is approximately 50% smaller than the US in terms of landmass, the population of Europe is approximately 50% larger and this presents a huge market opportunity.

Challenges In The Changing Outsourcing Landscape

October 1, 2011

Pharmaceutical Technology Europe

Oriol Prat, Marketing Manager, and Marga Viñes Senior Product Manager, from Grifols give us a quick rundown of how business is changing and what challenges the company faces.

Trends and Challenges in Biologics Outsourcing

October 1, 2011

Pharmaceutical Technology Europe

In a quick-fire interview, Dr Stephen Taylor, Vice President & Commercial Director at Fujifilm Diosynth Biotechnologies, looks at some of the challenges facing biologics outsourcing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
10%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here